Clinical Trial: Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional

Official Title: Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Brief Summary: 100 subjects who have a family history of pancreatic cancer (PC), or known genetic syndromes associated with increased risk of pancreatic cancer, will be followed for five years. This data will be used to determine the pancreatic cancer and precancerous lesion detection rate in High Risk Individuals (HRIs). Subjects may agree to annual imaging and annual biomarkers or to biomarkers only.

Detailed Summary:
Sponsor: University of Arkansas

Current Primary Outcome: Detection rate of PC and precancerous lesion [ Time Frame: 5 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Arkansas

Dates:
Date Received: December 3, 2014
Date Started: November 2015
Date Completion: November 2025
Last Updated: December 8, 2016
Last Verified: December 2016